The «microbiome» of post-liver transplant complications

The «microbiome» of post-liver transplant complications

This paper reviews modern literature and presents a brief analysis of our own data on one of the most pressing issues in modern transplantology and, in particular, transplant hepatology – the role and place of gut-liver axis (GLA) in the early post-transplant period. Objective: to compare the correl...

Full description

Bibliographic Details
Main Authors:	U. R. Salimov, I. O. Stoma, A. E. Scherba, A. M. Fedoruk, A. A. Kovalev, O. O. Rummo
Format:	Article
Language:	Russian
Published:	Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2022-07-01
Series:	Вестник трансплантологии и искусственных органов
Subjects:	liver transplantation bacterial complications gutliver axis hepatocellular carcinoma acute cellular rejection sequencing gut microbiota
Online Access:	https://journal.transpl.ru/vtio/article/view/1490

Similar Items

Sarcopenia in chronic liver disease, can we predict complications?
by: U. R. Salimov, et al.
Published: (2022-12-01)

Bacterial complications after liver transplantation. Promising directions for further research
by: U. R. Salimov, et al.
Published: (2023-06-01)

Crosstalk between Gut Microbiota and Hepatocellular Carcinoma
by: Chencheng Xie, et al.
Published: (2023-04-01)

Gut microbiota and mechanism of liver cancer
by: CHEN Congyan, WANG Junqing, CHEN Yongjun
Published: (2022-06-01)

Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
by: Wenyu Luo, et al.
Published: (2022-04-01)

Regulation of gut microbiota: a novel pretreatment for complications in patients who have undergone kidney transplantation
by: Jiajia Ye, et al.
Published: (2023-06-01)

Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma
by: Sancharan Acharya, et al.
Published: (2024-02-01)

Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis
by: Irina Efremova, et al.
Published: (2023-08-01)

The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies
by: Yongbo Kang, et al.
Published: (2021-12-01)

The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease
by: Tsung-Po Chen, et al.
Published: (2023-07-01)

Erratum: Modulation of Gut Microbiota by Magnesium Isoglycyrrhizinate Mediates Enhancement of Intestinal Barrier Function and Amelioration of Methotrexate-Induced Liver Injury
by: Frontiers Production Office
Published: (2022-07-01)

Modulation of Gut Microbiota by Magnesium Isoglycyrrhizinate Mediates Enhancement of Intestinal Barrier Function and Amelioration of Methotrexate-Induced Liver Injury
by: Yawen Xia, et al.
Published: (2022-05-01)

Brain-gut-liver axis: Chronic psychological stress promotes liver injury and fibrosis via gut in rats
by: Meng-Yang Xu, et al.
Published: (2022-12-01)

From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease
by: Andrea Pasta, et al.
Published: (2025-01-01)

Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
by: Li-Hong He, et al.
Published: (2021-11-01)

High-protein compound yogurt with quinoa improved clinical features and metabolism of high-fat diet–induced nonalcoholic fatty liver disease in mice
by: Linlin Shi, et al.
Published: (2023-08-01)

The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
by: Yi Gao, et al.
Published: (2021-04-01)

Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol
by: Arantza Lamas-Paz, et al.
Published: (2024-04-01)

Differences in risk factors for early-onset and late-onset biliary complications in liver transplant patients
by: Hsiu-Lung Fan, et al.
Published: (2015-01-01)

An urgent need for longitudinal microbiome profiling coupled with machine learning interventions
by: Priyankar Dey, et al.
Published: (2024-11-01)

Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis
by: Valeria Maccauro, et al.
Published: (2023-04-01)

Liver cirrhosis and complications from the perspective of dysbiosis
by: Guole Nie, et al.
Published: (2024-01-01)

Galangin alleviates alcoholic liver disease by regulating the gut-liver axis
by: Dongzhu Duan, et al.
Published: (2024-11-01)

The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease
by: Liang Zhao, et al.
Published: (2022-06-01)

Gut Microbiota and Chemical-Induced Acute Liver Injury
by: Tao Chen, et al.
Published: (2021-05-01)

Quinoa Reduces High-Fat Diet-Induced Obesity in Mice via Potential Microbiota-Gut-Brain-Liver Interaction Mechanisms
by: Ting-Ye Wang, et al.
Published: (2022-06-01)

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
by: Ludovico Abenavoli, et al.
Published: (2023-06-01)

Intestinal Microbiome in Dogs with Chronic Hepatobiliary Disease: Can We Talk about the Gut–Liver Axis?
by: Verena Habermaass, et al.
Published: (2023-10-01)

Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study
by: Bingren Hu, et al.
Published: (2024-12-01)

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Analysis on the change of gut microbiota and metabolome in lung transplant patients
by: Zhichao Hou, et al.
Published: (2024-04-01)

Updated Insights into Probiotics and Hepatobiliary Diseases
by: Xiaoyu Xu, et al.
Published: (2024-02-01)

Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
by: Jiachen Liu, et al.
Published: (2021-02-01)

Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver InjurySummary
by: Kai Markus Schneider, et al.
Published: (2021-01-01)

Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease
by: Jung A Eom, et al.
Published: (2023-12-01)

Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function
by: Prasant Kumar Jena, et al.
Published: (2020-11-01)

Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis
by: Irina Efremova, et al.
Published: (2024-02-01)

Editorial: Interplay between gut microbiota and the immune system in liver surgery and liver diseases
by: Julio Plaza-Díaz, et al.
Published: (2023-03-01)

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
by: Raquel Benedé-Ubieto, et al.
Published: (2024-12-01)

Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
by: Xuran Wang, et al.
Published: (2025-01-01)